Staehler, M. D., Kunte, S., Holzgreve, A., Unterrainer, M., Blajan, I., Stief, C. G., Bartenstein, P., Casuscelli, J., Unterrainer, L. (2025). 18 F-PSMA-1007 PET/CT for response assessment in patients with metastatic renal cell carcinoma undergoing first line tyrosine kinase or checkpoint inhibitor therapy.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.5_suppl.455